Suppr超能文献

灵芝和中华灵芝多糖的综合比较:化学性质、抗肿瘤、免疫调节和肠道微生物群调节特性。

Comprehensive comparison of polysaccharides from Ganoderma lucidum and G. sinense: chemical, antitumor, immunomodulating and gut-microbiota modulatory properties.

机构信息

School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.

School of Pharmacy, Xinxiang Medical University, Xinxiang, China.

出版信息

Sci Rep. 2018 Apr 18;8(1):6172. doi: 10.1038/s41598-018-22885-7.

Abstract

Both Ganoderma lucidum (GL) and G. sinense (GS) are used as Lingzhi in China. Their functions are assumed to mainly derive from triterpenes and polysaccharides; however, the two species have very different triterpenes profiles, if this was the case, then the bioactivity of these two species should differ. Instead, could the polysaccharides be similar, contributing to the shared therapeutic basis? In this study, two main polysaccharide fractions from different batches of GL and GS were systematically compared by a series of chemical and biological experiments. The results showed that the polysaccharides from two species shared the same structural features in terms of mono-/oligo-saccharide profiles, molecular size, sugar linkages, and IR/NMR spectra. In addition, these polysaccharides showed similar tumor-suppressive activity in mice. Further study on RAW264.7 cells indicated that these polysaccharides exhibited similar inducing effects to macrophages, as evaluated in the phagocytosis function, NO/cytokines production, inhibition against the viability and migration of cancer cells. Mechanistic investigation revealed the identical activation via TLR-4 related MAPK/NF-κB signaling pathway and gut-microbiota modulatory effects. In summary, GL and GS polysaccharides presented similar chemical features, antitumor/immunomodulating activities and mechanism; this establishes polysaccharides as the active principles and supports the official use of both species as Lingzhi.

摘要

灵芝在中国被分为赤芝(Ganoderma lucidum,GL)和紫芝(Ganoderma sinense,GS)。其功效主要被认为来自于三萜类化合物和多糖;然而,这两个种的三萜类化合物图谱却有很大的不同,如果是这样的话,那么这两个种的生物活性应该有所不同。相反,多糖是否可能相似,为共同的治疗基础做出贡献?在这项研究中,通过一系列的化学和生物学实验,对来自不同批次 GL 和 GS 的两种主要多糖成分进行了系统比较。结果表明,两种多糖在单糖/寡糖图谱、分子量、糖键和红外/核磁共振图谱方面具有相同的结构特征。此外,这些多糖在小鼠中表现出相似的肿瘤抑制活性。对 RAW264.7 细胞的进一步研究表明,这些多糖对巨噬细胞具有相似的诱导作用,如吞噬功能、NO/细胞因子产生、抑制癌细胞活力和迁移的评估。机制研究表明,它们通过 TLR-4 相关的 MAPK/NF-κB 信号通路和肠道微生物群调节作用发挥相同的作用。总之,GL 和 GS 多糖表现出相似的化学特征、抗肿瘤/免疫调节活性和机制;这确立了多糖作为活性成分,并支持将这两个种都作为灵芝使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b9d/5906605/6722619af0df/41598_2018_22885_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验